CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Amino acid supplement first day +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02987868
NCT02987868N/ACompleted

Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine

Pennington Biomedical Research Center·interventional·Posted Dec 9, 2016·Updated Feb 8, 2018

In Brief

A clinical study evaluating Amino acid supplement first day, Placebo first day, and 2 other interventions for Growth Hormone Treatment and Aging. Completed, enrolled 16 participants.

Detailed Summary

In a recent randomized, double-blind, cross-over clinical trial, serum growth hormone (hGH) increased 682% above baseline 120 minutes after oral administration of an amino acid-based dietary supplement (SeroVital), p=0.01 vs placebo. In contrast to the mechanism of hGH stimulation by ghrelin, the investigators hypothesize that the supplement suppresses somatostatin, a know inhibitor of both hGH and TSH. To test this hypothesis, the investigators measured triiodothyronine (T3) after administration of the amino acid-base supplement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 9, 2016
Enrollment StartOct 1, 2011
Primary CompletionDec 1, 2011
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.6 years ago

Interventions

Amino acid supplement first daydrug

An orally administered supplement of the proprietary amino acid derivative

Placebo first daydrug

A non-active orally administered supplement of the proprietary amino acid derivative

Amino acid supplement second daydrug

An orally administered supplement of the proprietary amino acid derivative

Placebo second daydrug

A non-active orally administered supplement of the proprietary amino acid derivative